Aiom: "Terapia adiuvante per cancro mammella può cambiare pratica clinica"
(Adnkronos) - Saverio Cinieri, presidente Aiom al Congresso Asco, ‘Terapia adiuvante con ribociclib rappresenta un altro grande passo in avanti per la ricerca clinica e la cura del tumore alla mammella. Italia ha avuto ruolo importante nello studio internazionale di fase III Natalee’
Category
🗞
NewsTranscript
00:00 (upbeat music)
00:02 (speaking in foreign language)
00:08 (speaking in foreign language)
00:12 (speaking in foreign language)
00:16 (speaking in foreign language)
00:20 (speaking in foreign language)
00:24 (speaking in foreign language)
00:28 (speaking in foreign language)
00:32 (speaking in foreign language)
00:36 (speaking in foreign language)
00:40 (speaking in foreign language)
00:43 (speaking in foreign language)
00:47 (speaking in foreign language)
00:51 important for the treatment of cancer of the jaw.